CartiHeal

📍 Kfar Saba, Israel🗓 Founded 2009👥 24 employees💰 Last funded 2017
Medical Equipment Manufacturing🌐 cartiheal.com
Website LinkedIn
CartiHeal, a privately-held medical device company with headquarters in Israel, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeal’s cell-free, off-the-shelf implant is CE marked for use in cartilage and osteochondral defects. Agili-C has been implanted in over 400 patients with cartilage lesions in the knee, ankle and great toe in a series of trials conducted in leading centers in Europe and Israel. In these trials, the implant was used to treat a broad spectrum of cartilage lesions, from single focal lesions to multiple and large defects in patients suffering from osteoarthritis. In the United States the Agili-C implant is not available for sale - it is an investigational device limited for use in the IDE study.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in CartiHeal?
CartiHeal has 1 investors on record on gritt.io and 1 late-stage investors.
When did CartiHeal last raise funding?
The most recent investment in CartiHeal recorded on gritt.io was in 2017.
When was CartiHeal founded?
CartiHeal was founded in 2009.
What industry is CartiHeal in?
CartiHeal operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is CartiHeal based?
CartiHeal is headquartered in Kfar Saba, Israel.